Anthony F. Kreft - Concepedia

Author

Anthony F. Kreft

Also Known As

A. F. III KREFT, A. F. KREFT, A. F. Kreft, A. KREFT, A. Kreft, A. Kreft, III, A.F. Kreft, Anthony F Kreft, Anthony F. Kreft, Anthony Kreft

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Princeton University Women's Health Research Institute Experimental Pathology Laboratories Arqule (United States)

About

Anthony F. Kreft is an author at Princeton University specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	19	868
2	Natural Sciences	8	8	192
3	Social Sciences	2	2	321
4	Engineering	1	1	33
5	Allergy	1	1	48

Anthony F. Kreft

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease Thomas A. Comery, Robert Martone, Suzan Aschmies, Journal of Neuroscience Acute TreatmentNeuropsychologyAffective NeuroscienceNeurochemical BiomarkersSwedish Mutation	2005	212
Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer’s Disease Robert Martone, Hua Zhou, Kevin Atchison, Journal of Pharmacology and Experimental Therapeutics	2009	157
Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1 Keith B. Glaser, Mei-Li Sung, Kim O’Neill, European Journal of Pharmacology Molecular PharmacologyMolecular PhysiologyBiochemistryG Protein-coupled ReceptorMedicine	1995	149
Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer’s Disease Scott C. Mayer, Anthony F. Kreft, Boyd L. Harrison, Journal of Medicinal Chemistry Stable Analogue 10Alzheimer ’Social SciencesNeuroinflammationAlzheimer's Disease	2008	109
Inhibition of platelet and neutrophil phospholipase A2 by hydroxyeicosatetraenoic acids (HETEs) A novel pharmacological mechanism for regulating free fatty acid release Joseph Chang, Eileen Blazek, Anthony F. Kreft, Biochemical Pharmacology InflammationThrombosisBiochemistryNeutrophil Phospholipase A2Hydroxyeicosatetraenoic Acids	1985	72
Stereochemistry of the SN2' reaction in cyclohexenyl systems Gerrit A. Stork, Anthony F. Kreft Journal of the American Chemical Society Molecular SciencesHeterocyclicChemical AnalysisAltmetric Attention ScoreOrganic Chemistry	1977	49
N-[(Arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure JOHN H. MUSSER, Anthony F. Kreft, Reinhold H. W. Bender, Journal of Medicinal Chemistry Pharmaceutical ScienceHydroxamic AcidsPharmacotherapyLtd4-induced ContractionMolecular Pharmacology	1990	48
Stereochemistry of the SN2' reaction. "Concerted" allylic displacement in an acyclic system: anti displacement with thiolate anion Gilbert Stork, Anthony F. Kreft Journal of the American Chemical Society Enantioselective SynthesisThiolate AnionMedicineMass SpectrometryAllylic Displacement	1977	44
Modulation by hydroxyeicosatetraenoic acids (HETEs) of arachidonic acid metabolism in mouse resident peritoneal macrophages Joseph Chang, Barbara Lamb, Laura Marinari, European Journal of Pharmacology InflammationAnti-inflammatoryArachidonic Acid MetabolismBiochemistryOmega-3 Fatty Acid	1985	35
Practical Enantioselective Synthesis of a 3-Aryl-3-trifluoromethyl-2-aminopropanol Derivative Asaf Alimardanov, Antonia A. Nikitenko, Terrence J. Connolly, Organic Process Research & Development Single IsomerAsymmetric CatalysisDerivativesEngineeringNatural Sciences	2009	33

Page 1